SAM #SPE2DP-27-R-ATRO

DLA sources Rafas atropine sulfate auto-injectors

DLA Troop Support Medical is seeking sources for a specific FDA-licensed atropine auto-injector used for emergency treatment of certain toxic exposures. - Government buyer: Department of Defense, Defense Logistics Agency (DLA), DLA Troop Support, Medical. - Requested product: Rafas Atropine Injection, Automatic, 2 mg atropine sulfate per 0.7 mL; NSN/part number 6505-31-017-0350. Each pressure-activated injector delivers 1.67 mg atropine base, equivalent to 2 mg atropine sulfate, for intramuscular administration. - Quantities: 90,000-unit minimum, 135,000-unit annual estimate, and 360,000-unit maximum per one-year term. Across the five-term ordering period, the corresponding totals are 450,000 minimum, 675,000 estimated, and 1,800,000 maximum units. - Notable requirements: Product must be FDA licensed and meet applicable FDA and NDA requirements, including NDA No. 212319. The injector must be suitable for rapid intramuscular use to treat muscarinic effects from nerve-agent or certain insecticide exposure. Shelf life is 36 months, with at least 24 months remaining at delivery. - Packaging: One injector is one unit; units are individually bagged, packed 40 per intermediate box and 12 boxes (480 units) per exterior container. - Delivery: FOB destination to DLA Distribution Susquehanna.

Description

Please see attached for the sources sought notice/market research survey and MPID.

View original listing